Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
EOLO PHARMA logo — Cutting-Edge Pharmacological Treatment for Obesity

EOLO PHARMA

Cutting-Edge Pharmacological Treatment for Obesity

Founded 2017 United States San Francisco, United States 12 employees Series Unknown Total: $4.50M Biopharma, Biotechnology +2

General Information

Company Name EOLO PHARMA
Founded Year 2017
Location United States San Francisco, United States +1
Employees 12
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Series Unknown
Social

Get notified when EOLO PHARMA moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About EOLO PHARMA

EOLO PHARMA is a biotechnology company founded in 2017. The company is focused on drug discovery, specifically on developing novel molecules for the treatment of obesity. Operating within the Biopharma, Biotechnology, Health Care, and Pharmaceutical industries, EOLO PHARMA is headquartered in the United States. The most recent milestone for EOLO PHARMA is the $1.80M Venture Round investment it secured on February 8, 2023. This financial backing will undoubtedly contribute to the company's ongoing research and development efforts, as well as its overall growth trajectory. As a biotechnology company specializing in obesity treatment, EOLO PHARMA occupies a significant position within the healthcare and biopharmaceutical sectors. This recent investment is a testament to the continued potential and promise that the industry sees in EOLO PHARMA's innovative approach to drug discovery.

Taxonomy: Drug Discovery, Obesity Treatment, Chronic Inflammation, Pharmaceuticals, Molecular Drugs, Inflammation-related Diseases, Small Molecules, Research and Development, Molecular Basis, Cellular Basis, Drug Development, Biomedical Technology, Therapeutic Molecules, Biomedical Research

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 08 Feb 2023
Series A •••••• 2
Investor
•••• •••• 		07 Jan 2020

EOLO PHARMA Alternatives & Competitors

EOLO PHARMA vs
Thetis Pharmaceuticals
Thetis Pharmaceuticals United States

Resolving disease without compromising host defense

Grant
4 employees
Biotechnology, Pharmaceutical
EOLO PHARMA vs
Calyxha Biotechnologies
Calyxha Biotechnologies Austria

A new perspective on inflammation

Seed
2 employees
Biotechnology
EOLO PHARMA vs
BridGene Biosciences
BridGene Biosciences

Utilizing advanced chemoproteomic technology to discover and develop highly selective small molecule...

Series B
11-50 employees
Biotechnology, Health and Wellness

FAQ About EOLO PHARMA

Cutting-Edge Pharmacological Treatment for Obesity
EOLO PHARMA was founded in 2017.
EOLO PHARMA is headquartered in San Francisco, United States.
EOLO PHARMA operates in the following industries: Biopharma, Biotechnology, Health Care, Pharmaceutical.
EOLO PHARMA has approximately 12 employees.
EOLO PHARMA has completed 2 funding rounds, raising a total of $4.50M. The latest funding stage is Series Unknown.
Top alternatives and competitors to EOLO PHARMA include Thetis Pharmaceuticals, Calyxha Biotechnologies, BridGene Biosciences, Alivio Therapeutics, Orbit Discovery. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EOLO PHARMA and Thetis Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors EOLO PHARMA and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes